课题基金 / 基金详情

RESERCH ON THE RELATIONSHIP BETWEEN THE CELLULAR IMMUNITY AND CLINCAL PICTURE ON VOGT-KOYANAGI-HARADA DISEASE.

RESERCH ON THE RELATIONSHIP BETWEEN THE CELLULAR IMMUNITY AND CLINCAL PICTURE ON VOGT-KOYANAGI-HARADA DISEASE.
VOGT-小柳-原田病细胞免疫与临床表现之间关系的研究。
批准号:
04671070
负责人:
NOROSE Kazumi
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

NOROSE Kazumi的其他基金

相似基金

相关文献

中文摘要
翻译
Vogt-Koyanagi-Harada病(VKH)被认为是一种全身性疾病,影响含有黑素细胞的各种器官。黑素细胞特异性细胞毒性T淋巴细胞(CTL)在VKH的发生和发展中起重要作用。本研究分析了抗HLAI类和抗HLACalss II抗体对人黑色素瘤细胞系(P-36)特异性CTL的阻断作用。对P-36的杀伤作用可被抗HLACalss II抗体阻断,但不能被抗HLAI类抗体阻断。根据这些结果,P-36特异性CTL识别黑色素瘤抗原和P-36的HLAII类分子的复合体。此外,我们建立了黑色素瘤特异性CTL细胞系(SF-1),来自VKH患者,通过在IL-2刺激下用P-36长期培养外周血白细胞。SF-1对P-36有较强的细胞毒作用。流式细胞仪分析表明,SF-1的表面标志为CD4^+CD8^-HLA-DR^+CD25^+TCRalphabeta^+TCRgammadelta^-.SF-1产生极高水平的IL-6和显著水平的IL-2和干扰素-γ。因此,黑色素瘤特异性CTL产生的淋巴因子可能在VKH的免疫发病机制中起重要作用。此外,我们还建立了SF-1与T细胞肿瘤细胞株(CEM)的杂交瘤。杂交瘤细胞的表面标记为CD2^+CD4^+CD8^-CD25^<(〕SY.+-.〔)>HLA-DR^-TCRalphabeta^<(〕SY.+-.〔)>TCRgammadelta^-CD11a^+CD28^+.虽然这些杂交瘤细胞与P-36黏附,但对P-36无细胞毒作用,并且在杂交瘤细胞培养上清液中未检测到IL-2、IL-6和干扰素-γ。
英文摘要
Vogt-Koyanagi-Harada disease (VKH) is thought to be a systemic disorder affecting various organs containing melanocytes. Melanocyte-specific cytotoxic T lymphocytes (CTL) in VKH have been assumed to be generated and to play an important role in the manifestation of this disease.In this study, we analyzed the blocking effects of anti-HLA class I and anti-HLA calss II antibodies against the cytotoxicity of human melanoma cell line(P-36)-specific CTL.Cytoxicities against P-36 were assayd by % specific ^<51>Cr release. The cytotoxicity against P-36 was blocked by anti-HLA calss II antibody but not by anti-HLA class I antibody. From these results P-36-specific CTL recognized the complex of melanoma antigen and HLA-class II molecules of P-36. Furthermore, we established a melanoma-specific CTL cell line(SF-1) from a patient with VKH by long term culture of peripheral blood leukocytes with P-36 under IL-2 stimulation. SF-1 showed strong cytotoxicity against P-36. Flow cytometric analysis revealed that the surface markers of SF-1 were CD4^+CD8^-HLA-DR^+CD25^+TCRalphabeta^+TCRgammadelta^-. SF-1 produced extreamly high level of IL-6 and significant levels of IL-2 and IFN-gamma. Thus, lymphokines produced by melanoma-specific CTL may play an important role in the immunopathogenesis of VKH.Additionaly, we established hybridomas of SF-1 and T cell tumor cell line(CEM). The surface markers of the hybridomas were CD2^+CD4^+CD8^-CD25^<(〕SY.+-.〔)>HLA-DR^-TCRalphabeta^<(〕SY.+-.〔)>TCRgammadelta^-CD11a^+CD28^+. Although these hybridomas adhered to P-36, it did not show cytotoxicity against P-36 and IL-2, IL-6 and IFN-gamma were not detected in the supernate of these hybridomas.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Norose K,et al: "Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease." Invest Ophthalmol Vis Sci. 35. 33-39 (1994)
Norose K 等人:“Vogt-Koyanagi-Harada 病中房水中活化 T 细胞和白细胞介素 6 的优势。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aosai F,et al: "Isolation of naturally processed peptides from Toxoplasma-gondii-infected human B lymphoma as recognized by cytotoxic T lymphocytes." J Parasitol. (in press).
Aosai F 等人:“从弓形虫感染的人 B 淋巴瘤中分离出自然加工的肽,并被细胞毒性 T 淋巴细胞识别。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 7 条
    Establishment of the detection method for the reactivation of toxoplasmosis and the evaluatiion method for the severity of toxoplasmosis by mass spectrometer
    • 批准号:
      17KT0124
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2017
    • 负责人:
      NOROSE Kazumi
    • 依托单位:
    Analysis of mechanisms of protozoan invasion into the retinal endothelium of congenital toxoplasmic retinochoroiditis
    • 批准号:
      20592071
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      NOROSE Kazumi
    • 依托单位:
    Molecular pathogenetic analysis of blood vessels in toxoplasmic retinochoroiditis
    • 批准号:
      17591822
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2005
    • 负责人:
      NOROSE Kazumi
    • 依托单位:
    cDNA microarray analysis of toxoplasmic retinochoroiditis
    • 批准号:
      14571657
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      NOROSE Kazumi
    • 依托单位:
    海外基金